• The study's lead author, Jonathan Sackner-Bernstein of North Shore University Hospital in Manhassett, N.

    FORBES: Magazine Article

  • Study co-author Jonathan Sackner-Bernstein, director of the clinical research at North Shore University Hospital in Manhasset, N.

    FORBES: Study Raises Concerns About J&J Drug

  • Packer's unease springs from the work of Jonathan Sackner-Bernstein , a heart failure expert at North Shore University Hospital in Manhasset, N.

    FORBES: A Safety Question For J&J

  • Reached for comment, Jonathan Sackner-Bernstein of the research firm CliniLabs said that he "always hoped to be proved wrong" about the safety worries.

    FORBES: Magazine Article

  • Safety issues about Natrecor were raised by Jonathan Sackner-Bernstein , a New York cardiologist, and Keith Aaronson , a researcher at the University of Michigan.

    FORBES: Cardiologist Calls For Limits On J&J Drug

  • Two years ago a pair of cardiologists, Jonathan Sackner-Bernstein and Keith Aaronson, published a series of papers arguing that Natrecor was not safe, based on existing clinical trials.

    FORBES: Debate Over J&J Heart Failure Drug Continues

  • Jonathan Sackner-Bernstein, of the clinical research outfit CliniLabs, says that data on Merck's drug rolofylline "look pretty impressive, " although he does worry about seizures or other side effects cropping up in late-stage trials.

    FORBES: Is Merck Flying Blind?

  • Undaunted, CHF's Erb hopes to begin selling machines to outpatient clinics, though another skeptic, Jonathan Sackner-Bernstein at CliniLabs in New York, says that rollout is "premature, " preferring its use be kept at hospitals.

    FORBES: Magazine Article

  • In a statement, Jonathan Sackner-Bernstein, a New York cardiologist who co-authored the papers that warned of Natrecor's alleged safety risks, wrote that the results provide hope that there will be new therapies for acute heart failure.

    FORBES: Magazine Article

  • At medical meetings and in the journals Circulation and The Journal of the American Medical Association, Jonathan Sackner-Bernstein of North Shore University Hospital and Keith Aaronson of the University of Michigan fretted that Natrecor might cause kidney problems or even an increase in mortality.

    FORBES: Bitter Pill For J&J On Heart Drug

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定